CLINICAL_TRIALS trial_result · 2023-02-17

Clinical Trial Update: A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients [Phase 2]

Phase 2 trial of ABI-H0731 plus nucleos(t)ide as finite treatment for chronic hepatitis B was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Assembly Biosciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: TERMINATED | Results posted: 2023-02-17